XORTX Pharma's Reverse Merger Round

XORTX Pharma raised a round of funding on January 10, 2018. Investors include APAC Resources.

XORTX Pharma is a drug development company primarily focused on orphan disease indications which have a uric acid imbalance as well as metabolic syndrome, diabetes and diabetic nephropathy.…

Articles about XORTX Pharma's Reverse Merger Round: